Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

SELL
$20.12 - $35.09 $5,030 - $8,772
-250 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$29.06 - $38.83 $17,436 - $23,298
-600 Reduced 70.59%
250 $7,000
Q4 2020

Feb 09, 2021

BUY
$42.46 - $56.58 $25,476 - $33,948
600 Added 240.0%
850 $39,000
Q3 2020

Nov 05, 2020

BUY
$37.44 - $64.63 $9,360 - $16,157
250 New
250 $11,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $83.5M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.